Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3.

Loetscher P, Pellegrino A, Gong JH, Mattioli I, Loetscher M, Bardi G, Baggiolini M, Clark-Lewis I.

J Biol Chem. 2001 Feb 2;276(5):2986-91. Epub 2000 Nov 10.

2.

The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.

Zeremski M, Petrovic LM, Talal AH.

J Viral Hepat. 2007 Oct;14(10):675-87. Review.

PMID:
17875002
3.

Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications.

Amerio P, Frezzolini A, Feliciani C, Verdolini R, Teofoli P, De Pità O, Puddu P.

Curr Drug Targets Inflamm Allergy. 2003 Mar;2(1):81-94. Review.

PMID:
14561178
4.

CCR3 blockade as a new therapy for asthma.

Bertrand CP, Ponath PD.

Expert Opin Investig Drugs. 2000 Jan;9(1):43-52. Review.

PMID:
11060659
5.

Chemokines, chemokine receptors and allergy.

Kaplan AP.

Int Arch Allergy Immunol. 2001 Apr;124(4):423-31. Review.

PMID:
11340325
6.

Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.

Müller M, Carter S, Hofer MJ, Campbell IL.

Neuropathol Appl Neurobiol. 2010 Aug;36(5):368-87. doi: 10.1111/j.1365-2990.2010.01089.x. Epub 2010 May 6. Review.

PMID:
20487305
7.

Regulation of chemokine receptor expression in eosinophils.

Nagase H, Miyamasu M, Yamaguchi M, Fujisawa T, Kawasaki H, Ohta K, Yamamoto K, Morita Y, Hirai K.

Int Arch Allergy Immunol. 2001;125 Suppl 1:29-32. Review.

PMID:
11408769
8.

The MCP/eotaxin subfamily of CC chemokines.

Van Coillie E, Van Damme J, Opdenakker G.

Cytokine Growth Factor Rev. 1999 Mar;10(1):61-86. Review.

PMID:
10379912
9.

Effects of CC, CXC, C, and CX3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors.

Broxmeyer HE, Kim CH, Cooper SH, Hangoc G, Hromas R, Pelus LM.

Ann N Y Acad Sci. 1999 Apr 30;872:142-62; discussion 163. Review.

PMID:
10372118
10.

[Chemokines and chemokine receptors in multiple sclerosis].

Misu T, Fujihara K, Itoyama Y.

Nihon Rinsho. 2003 Aug;61(8):1422-7. Review. Japanese.

PMID:
12962033
11.

[Chemokine (RANTES, eotaxin, etc.)].

Saito N, Chihara J.

Nihon Rinsho. 2001 Oct;59(10):1900-5. Review. Japanese.

PMID:
11676129
12.

Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation.

Luster AD, Rothenberg ME.

J Leukoc Biol. 1997 Nov;62(5):620-33. Review.

PMID:
9365117
13.

CCL chemokines and asthma.

Teran LM.

Immunol Today. 2000 May;21(5):235-42. Review.

PMID:
10782055
14.

Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues.

Rothenberg ME.

Am J Respir Cell Mol Biol. 1999 Sep;21(3):291-5. Review. No abstract available.

PMID:
10460744
15.

The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention.

Cascieri MA, Springer MS.

Curr Opin Chem Biol. 2000 Aug;4(4):420-7. Review.

PMID:
10959770
16.

CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication.

Singh UP, Venkataraman C, Singh R, Lillard JW Jr.

Endocr Metab Immune Disord Drug Targets. 2007 Jun;7(2):111-23. Review.

PMID:
17584151
18.

Chemoattractant receptors expressed on type 2 T cells and their role in disease.

Cosmi L, Annunziato F, Maggi E, Romagnani S, Manetti R.

Int Arch Allergy Immunol. 2001 Aug;125(4):273-9. Review.

PMID:
11574748
19.

Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection.

Larrubia JR, Benito-Martínez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T.

World J Gastroenterol. 2008 Dec 21;14(47):7149-59. Review.

20.

Chemokines and atherosclerosis.

Terkeltaub R, Boisvert WA, Curtiss LK.

Curr Opin Lipidol. 1998 Oct;9(5):397-405. Review.

PMID:
9812193

Supplemental Content

Support Center